About Meridian Bioscience
Meridian Bioscience, Inc. is a life science company engaged in the development, manufacture, sale and distribution of diagnostic test kits for gastrointestinal, viral, respiratory and parasitic infectious diseases, and elevated blood lead levels, and the manufacture and distribution of bulk antigens, antibodies, polymerase chain reaction (PCR)/quantitative PCR (qPCR) reagents, nucleotides, competent cells and bioresearch reagents used by researchers and other diagnostic manufacturers. Its segments include Diagnostics and Life Science. The Diagnostics segment includes manufacturing operations in Cincinnati, and the sale and distribution of diagnostic test kits in the countries consisting of North, Central and South America; Europe, the Middle East and Africa (EMEA), and other countries outside of the Americas and EMEA. The Life Science segment consists of manufacturing operations in Memphis, Tennessee; Boca Raton, Florida; London, England; Luckenwalde, Germany, and Sydney, Australia.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Diagnostic Substances
- Sub-Industry: Health Care Supplies
- Exchange: NASDAQ
- Symbol: VIVO
- CUSIP: 58958410
- Previous Close: $12.75
- 50 Day Moving Average: $14.52
- 200 Day Moving Average: $17.31
- 52-Week Range: $10.75 - $21.49
- Trailing P/E Ratio: 17.86
- Foreward P/E Ratio: 18.12
- P/E Growth: 1.14
- Market Cap: $527.53M
- Outstanding Shares: 42,202,000
- Beta: 1
- Net Margins: 15.13%
- Return on Equity: 18.51%
- Return on Assets: 12.23%
Companies Related to Meridian Bioscience:
- Debt-to-Equity Ratio: 0.32%
- Current Ratio: 5.99%
- Quick Ratio: 3.87%
What is Meridian Bioscience's stock symbol?
Meridian Bioscience trades on the NASDAQ under the ticker symbol "VIVO."
How often does Meridian Bioscience pay dividends? What is the dividend yield for Meridian Bioscience?
Meridian Bioscience declared a quarterly dividend on Wednesday, January 25th. Investors of record on Monday, February 6th will be paid a dividend of $0.125 per share on Thursday, February 16th. This represents a $0.50 annualized dividend and a yield of 4.00%. The ex-dividend date of this dividend is Thursday, February 2nd.
Where is Meridian Bioscience's stock going? Where will Meridian Bioscience's stock price be in 2017?
5 equities research analysts have issued 1-year target prices for Meridian Bioscience's stock. Their forecasts range from $9.00 to $22.00. On average, they anticipate Meridian Bioscience's share price to reach $17.60 in the next twelve months.
When will Meridian Bioscience announce their earnings?
Meridian Bioscience is scheduled to release their next quarterly earnings announcement on Wednesday, April, 26th 2017.
Who owns Meridian Bioscience stock?
Meridian Bioscience's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Brown Capital Management LLC (13.52%), Renaissance Technologies LLC (4.44%), Dimensional Fund Advisors LP (3.32%), State Street Corp (2.57%), Prudential PLC (2.42%) and Fred Alger Management Inc. (0.92%). Company insiders that own Meridian Bioscience stock include Catherine Sazdanoff, Dwight E Ellingwood, John A Kraeutler, John Mcilwraith, Lawrence Baldini, Marviette D Johnson, Melissa Lueke, Richard Eberly and Vecheslav A Elagin.
Who sold Meridian Bioscience stock? Who is selling Meridian Bioscience stock?
Meridian Bioscience's stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, AQR Capital Management LLC, Brown Capital Management LLC, Guggenheim Capital LLC, Keybank National Association OH, Tudor Investment Corp Et Al, State Board of Administration of Florida Retirement System and Numeric Investors LLC. Company insiders that have sold Meridian Bioscience stock in the last year include Richard Eberly and Vecheslav A Elagin.
Who bought Meridian Bioscience stock? Who is buying Meridian Bioscience stock?
Meridian Bioscience's stock was purchased by a variety of institutional investors in the last quarter, including Discovery Group I LLC, State Street Corp, FMR LLC, Flinton Capital Management LLC, Two Sigma Investments LP, Tyers Asset Management LLC, Fred Alger Management Inc. and Royce & Associates LP. Company insiders that have bought Meridian Bioscience stock in the last two years include Catherine Sazdanoff, Dwight E Ellingwood, John A Kraeutler, John Mcilwraith, Lawrence Baldini and Melissa Lueke.
How do I buy Meridian Bioscience stock?
Shares of Meridian Bioscience can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Meridian Bioscience stock cost?
One share of Meridian Bioscience stock can currently be purchased for approximately $12.50.